Optogenetic manipulation of lysosomal physiology and autophagy-dependent clearance of amyloid beta

PLoS Biol. 2024 Apr 23;22(4):e3002591. doi: 10.1371/journal.pbio.3002591. eCollection 2024 Apr.

Abstract

Lysosomes are degradation centers of cells and intracellular hubs of signal transduction, nutrient sensing, and autophagy regulation. Dysfunction of lysosomes contributes to a variety of diseases, such as lysosomal storage diseases (LSDs) and neurodegeneration, but the mechanisms are not well understood. Altering lysosomal activity and examining its impact on the occurrence and development of disease is an important strategy for studying lysosome-related diseases. However, methods to dynamically regulate lysosomal function in living cells or animals are still lacking. Here, we constructed lysosome-localized optogenetic actuators, named lyso-NpHR3.0, lyso-ArchT, and lyso-ChR2, to achieve optogenetic manipulation of lysosomes. These new actuators enable light-dependent control of lysosomal membrane potential, pH, hydrolase activity, degradation, and Ca2+ dynamics in living cells. Notably, lyso-ChR2 activation induces autophagy through the mTOR pathway, promotes Aβ clearance in an autophagy-dependent manner in cellular models, and alleviates Aβ-induced paralysis in the Caenorhabditis elegans model of Alzheimer's disease. Our lysosomal optogenetic actuators supplement the optogenetic toolbox and provide a method to dynamically regulate lysosomal physiology and function in living cells and animals.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease / genetics
  • Alzheimer Disease / metabolism
  • Amyloid beta-Peptides* / metabolism
  • Animals
  • Autophagy* / physiology
  • Caenorhabditis elegans* / metabolism
  • Caenorhabditis elegans* / physiology
  • Calcium / metabolism
  • HEK293 Cells
  • HeLa Cells
  • Humans
  • Hydrogen-Ion Concentration
  • Lysosomes* / metabolism
  • Optogenetics* / methods
  • TOR Serine-Threonine Kinases / metabolism

Substances

  • Amyloid beta-Peptides
  • Calcium
  • TOR Serine-Threonine Kinases

Grants and funding

This work was supported by the Strategic Priority Research Program of the Chinese Academy of Sciences (https://english.cas.cn/) (grant XDB39020400 to C.C.), the National Natural Science Foundation of China (https://www.nsfc.gov.cn/english/site_1/index.html) (grants 31770896, 32270732 to C.C.), and The Global Select Project (DJK-LX-202202 to C.C.) of the Institute of Health and Medicine, Hefei Comprehensive National Science Center (https://www.ihm.ac.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.